

HY-171777 · 50 mg
MedChemExpress · Cat: HY-171777
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/erufosine.htmlDescription
Erufosine is an inhibitor of PI3K/Akt and Ras/Raf/MAPK signaling pathways. Erufosine inhibits the activity of breast cancer cell lines MCF-7 and MDA-MB 231 IC50: 40.95/40.8 ?M . Erufosine reduces the phosphorylation of PI3K p85 , Akt PKB , and cRaf. Erufosine can be used in the study of breast cancer and myeloid leukemia.







